| P50 | author | Enrico Mastrobattista | Q85280485 |
| | Tanja D de Gruijl | Q90913412 |
| P2093 | author name string | Yvette van Kooyk | |
| | Cynthia M Fehres | |
| | Anastasia Lanzi | |
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| | High-throughput screening of enzyme libraries: in vitro evolution of a beta-galactosidase by fluorescence-activated sorting of double emulsions. | Q33229577 |
| | Cell-free protein synthesis: applications in proteomics and biotechnology | Q33368945 |
| | Danger signals: SOS to the immune system | Q33931055 |
| | Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects | Q34334155 |
| | Vaccines: past, present and future | Q34409178 |
| | Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine | Q35175380 |
| | A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction | Q35787391 |
| | Technologies for enhanced efficacy of DNA vaccines | Q35802958 |
| | PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines | Q35961182 |
| | Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 |
| | The perfect mix: recent progress in adjuvant research | Q36844715 |
| | Methods of endotoxin removal from biological preparations: a review | Q36922614 |
| | Nanotechnology in vaccine delivery | Q37104199 |
| | Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines. | Q37294066 |
| | Activation of dendritic cells by toll-like receptors and C-type lectins | Q37334043 |
| | Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation | Q37363754 |
| | Nanovaccines: recent developments in vaccination | Q37679570 |
| | The wheat-germ cell-free expression system | Q37704483 |
| | Liposomal vaccine delivery systems | Q37854063 |
| | DNA fusion vaccines enter the clinic. | Q37885288 |
| | Developments in virus-like particle-based vaccines for infectious diseases and cancer | Q37951525 |
| | Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity | Q40279113 |
| | Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells | Q43120646 |
| | Cell-free translation reconstituted with purified components | Q43692142 |
| | Optimization and quantification of protein synthesis inside liposomes | Q44811319 |
| | A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. | Q53619786 |
| | CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts | Q63312881 |
| | Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors | Q64378395 |
| | Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine | Q73594807 |
| | Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression | Q74183188 |
| | Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes | Q84915322 |
| P433 | issue | 2 | |
| P921 | main subject | dendritic cell | Q506253 |
| | chemotaxis | Q658145 |
| P304 | page(s) | 516-526 | |
| P577 | publication date | 2013-09-26 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants | |
| P478 | volume | 31 | |